Coustan Donald R, Lowe Lynn P, Metzger Boyd E
Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Women & Infants Hospital of Rhode Island, 101 Dudley Street, Providence, RI 02905-2401, USA.
J Matern Fetal Neonatal Med. 2010 Mar;23(3):204-9. doi: 10.3109/14767050903550667.
At present the diagnosis of gestational diabetes uses differing criteria in different parts of the world, with none being based on pregnancy outcome. Different glucose loads (50, 75 or 100 grams) are recommended, rather than the standard 75 gram load utilized worldwide in nonpregnant individuals. The HAPO study was designed to determine what level of glucose intolerance, short of diabetes, is associated with an excess of adverse perinatal outcomes. On a 75 gram, 2-hour OGTT each of the 3 values is significantly and continuously related to various adverse outcomes, and no inflection point is evident. Consequently an international group of interested experts is developing recommendations for diagnostic criteria for GDM which, it is hoped, will be adopted world wide.
目前,世界不同地区对妊娠期糖尿病的诊断采用不同的标准,且均未基于妊娠结局。推荐使用不同的葡萄糖负荷量(50克、75克或100克),而非全球非妊娠个体所采用的标准75克负荷量。高血糖与不良妊娠结局研究(HAPO研究)旨在确定何种程度的糖耐量异常(未达到糖尿病程度)与围产期不良结局增加相关。在75克2小时口服葡萄糖耐量试验中,三个值中的每一个都与各种不良结局显著且持续相关,且无明显拐点。因此,一个由感兴趣的国际专家小组正在制定妊娠期糖尿病诊断标准的建议,希望能在全球采用。